Abdulqadir Nashwan is the Director of Nursing for Education and Practice Development at HMGH and is a Member of Hamad Medical Corporation (HMC) in Qatar. He received his bachelor's degree in Nursing (BSN) in 2007 and master's degree in Nursing Oncology (MSN) in 2011 from the Hashemite University (HU) in Jordan. He has assumed different educational, research, and managerial roles in nursing. In 2015, he was appointed as a senior adjunct Instructor at the faculty of nursing at the University of Calgary in Qatar (UCQ). His current research interests include Research Utilization, Evidenced-Based Practice, Clinical Hematology/Oncology, Nursing Informatics. Mr. Nashwan has published more than 250 research articles in peer-reviewed journals. In November 2015, he received the Award of Merit for Placing HMC at the Cutting Edge of Cancer Research as a part of the Stars of Excellence Program introduced by HMC. In October 2016, Mr. Nashwan completed a Cancer Biology & Therapeutics (CBT) Program, provided by Harvard Medical School (HMS). His current h-index is 15 and i10-index is 21. He is currently pursuing a PhD in Health Sciences at the College of Medicine - Qatar University (QU). Mr. Nashwan has been committed to mentoring and encouraging young clinical investigators throughout his career; he has formally supervised the training of more than a dozen MSc candidates and nursing fellows. His expertise is routinely sought in an advisory capacity both nationally and internationally. Also, he has served as a reviewer for several reputable journals.
